Which medication category is currently expanding nearly as quickly as generics? Biosimilars.
Approvals from the US Food and Drug Administration (FDA) for generic medications experienced strong growth in 2021, with 80+ first generics approved thus far. And the year is not quite over, so that number could go even higher. Generic medications offer the potential for significant cost savings for patients, as well as expanded choices for treatment plans. But generics are not the only way to save money; there’s also biosimilars.
Biosimilar medications are sometimes confused with generics. Generics are identical to brand-name drugs. Biosimilars are similar (but not identical) to an original biologic medication. However, like generics, biosimilars are safe and effective while also being a far less expensive option compared to brand-name medications.
Biosimilars tend to be large complex molecules manufactured in living systems that are almost, but not exactly, the same medication as the original biologic. Although the two medications will not be identical, in order to gain FDA approval, the biosimilar must have the same safety, purity, and potency and there can be no clinically meaningful differences in their uses.
In 2021, the FDA approved 31 new biosimilar medications. Each of these serve as high-quality alternatives for treatment, yet at a fraction of the cost for many patients.
As always, BioPlus Specialty Pharmacy is ready to partner with your office as the ‘fast & easy’ way to get your patients referred for the specialty medications they need.
Related Posts
Crohn’s Disease: Heading Toward its 100th Birthday
Could a cure for Crohn’s disease be in the future? There are several research directions that are...
The Biosimilar Bandwagon
Biosimilars are safe, effective, and affordable alternatives to certain costly brand biologic...
BioPlus Infusion’s Lisa Hill Joins ACHC/IgNS Steering Committee for Centers of Excellence Accreditation Initiative
BioPlus Infusion’s very own Lisa Hill, National Director of Nursing and Clinical Services, has been...
2019 Looks Brighter for MS
Welcome to 2019: a year that holds some exciting developments for multiple sclerosis medication...